Satoru Aoyama
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Clinical significance of comprehensive genomic profiling in hematopoietic failure
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: July 08, 2026
Correction: Exploratory analysis of gene aberrations and chemotherapy response: findings from a real-world database in Japan.
Journal: British journal of cancer
Published: March 30, 2026
A novel fumarate hydratase frameshift mutation in lung adenocarcinoma: A case report.
Journal: Cancer genetics
Published: June 10, 2025
Exploratory analysis of gene aberrations and chemotherapy response: findings from a real-world database in Japan.
Journal: British journal of cancer
Published: April 09, 2025
Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients.
Journal: Oncotarget
Published: March 12, 2025
Identification of risk factors for gastrointestinal immune-related adverse events associated with immune check point inhibitors.
Journal: Expert opinion on drug safety
Published: December 17, 2024
Evaluation of therapeutic agent selection based on comprehensive genomic profiling in gastroenteropancreatic neuroendocrine neoplasms.
Journal: PloS one
Published: December 09, 2024
Tumor progression locus 2, a new potential prognostic factor and therapeutic target in activated B-cell-like diffuse large B-cell lymphoma.
Journal: Blood cancer journal
Published: August 21, 2024
A case of double-negative prostate cancer with BRCA2 mutation and high tumor mutation burden treated sequentially with olaparib and pembrolizumab.
Journal: IJU case reports
Published: April 16, 2024
A novel chimeric antigen receptor (CAR) system using an exogenous protease, in which activation of T cells is controlled by expression patterns of cell‑surface proteins on target cells.
Journal: International journal of molecular medicine
Published: November 05, 2021
MPL overexpression induces a high level of mutant-CALR/MPL complex: a novel mechanism of ruxolitinib resistance in myeloproliferative neoplasms with CALR mutations.
Journal: International journal of hematology
Published: March 22, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026